Evaluation of the effects of ranibizumab (Lucentis ® ) therapy on the macular function in patients with wet age-related macular degeneration using multifocal-electroretinogram and microperimetry

Mihaela Reinsberg, R.-D. Hilgers, J. Lüke, K. Nassar, S. Grisanti, I. Lüdeke & M. Lüke
Purpose: The purpose of this study was to evaluate the macular function under the treatment with ranibizumab (Lucentis®) in wet age-related macular degeneration (AMD) observed by multifocalelectroretinogram (ERG) and microperimetry. Methods: Twenty subjects with neovascluar AMD meeting the [for full text, please go to the a.m. URL]